La Jolla Pharmaceutical (LJPC) Misses Q2 EPS by 7c

La Jolla Pharmaceutical (NASDAQ: LJPC) reported Q2 EPS of ($2.02), $0.07 worse than the analyst estimate of ($1.95). Revenue for the quarter came in at $1.59 million versus the consensus estimate of $2.4 million.

For earnings history and earnings-related data on La Jolla Pharmaceutical (LJPC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c